# Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.

> **NCT00255619** · PHASE4 · COMPLETED · sponsor: **Ministry of Health, Malaysia** · enrollment: 264 (—)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **DEVICE:** Baxter's UltraBag® and FMC Andy·Disc®

## Key facts

- **NCT ID:** NCT00255619
- **Lead sponsor:** Ministry of Health, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 264 (—)
- **Last updated:** 2006-10-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255619, "Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00255619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*